相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure
Wesley Tyler Abplanalp et al.
CIRCULATION RESEARCH (2021)
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice
Yoshimitsu Yura et al.
CIRCULATION RESEARCH (2021)
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Xingyi Pan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial
Arndt Stahler et al.
EUROPEAN JOURNAL OF CANCER (2020)
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
S. Stintzing et al.
ANNALS OF ONCOLOGY (2019)
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation
Mareike Frick et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Christopher Maximilian Arends et al.
LEUKEMIA (2018)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Jose J. Fuster et al.
SCIENCE (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
Sebastian Stintzing et al.
LANCET ONCOLOGY (2016)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
Jeremy Dupaul-Chicoine et al.
IMMUNITY (2015)
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Volker Heinemann et al.
LANCET ONCOLOGY (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
De Novo DNA Methylation Is Required to Restrict T Helper Lineage Plasticity
Rajan M. Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of DNA Methyltransferase 3a as a T Cell Receptor-Induced Regulator of Th1 and Th2 Differentiation
Christopher J. Gamper et al.
JOURNAL OF IMMUNOLOGY (2009)
分享论文
